Literature DB >> 16236484

P2Y12 receptor signalling towards PKB proceeds through IGF-I receptor cross-talk and requires activation of Src, Pyk2 and Rap1.

Kristof Van Kolen1, Kambiz Gilany, Luc Moens, Eddy L Esmans, Herman Slegers.   

Abstract

Previously it was shown that stimulation of the P2Y12 receptor activates PKB signalling in C6 glioma cells [K. Van Kolen and H. Slegers, J. Neurochem. 89, 442.]. In the present study, the mechanisms involved in this response were further elucidated. In cells transfected with the Gbetagamma-scavenger beta-ARK1/GRK2 or Rap1GAPII, stimulation with 2MeSADP failed to enhance PKB phosphorylation demonstrating that the signalling proceeds through Gbetagamma-subunits and Rap1. Moreover, Rap1-GTP pull-down assays revealed that P2Y12 receptor stimulation induced a rapid activation of Rap1. Treatment of cells with the Ca2+ chelator BAPTA-AM and inhibition of Src and PLD2 with PP2 or 1-butanol, respectively, abrogated P2Y12 receptor-mediated activation of Rap1 and PKB. In addition inhibition of PKCzeta decreased basal and 2MeSADP-stimulated phosphorylation of PKB indicating a role for this PKC isoform in PKB signalling. Although the increased PKB phosphorylation was abolished in the presence of the IGF-I receptor tyrosine kinase inhibitor AG 1024, 2MeSADP did not significantly increase receptor phosphorylation. Nevertheless, phosphorylation of a 120 kDa IGF-I receptor-associated protein was observed. The latter protein was identified by MALDI-TOF/TOF-MS as the proline-rich tyrosine kinase 2 (Pyk2) that co-operates with Src in a PLD2-dependent manner. Consistent with the signalling towards Rap1 and PKB, activation of Pyk2 was abrogated by Ca2+ chelation, inhibition of PLD2 and IGF-I receptor tyrosine kinase activity. In conclusion, the data reveal a novel type of cross-talk between P2Y12 and IGF-I receptors that proceeds through Gbetagamma-, Ca2+-and PLD2-dependent activation of the Pyk2/Src pathway resulting in GTP-loading of Rap1 required for an increased PKB phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236484     DOI: 10.1016/j.cellsig.2005.09.005

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  15 in total

Review 1.  Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release.

Authors:  Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2015-11-06       Impact factor: 3.765

Review 2.  Interaction of P2 purinergic receptors with cellular macromolecules.

Authors:  Laszlo Köles; Zoltan Gerevich; João Felipe Oliveira; Zoltan Sandor Zadori; Kerstin Wirkner; Peter Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

3.  P2Y(1) and P2Y(12) receptor cross-talk in calcium signalling: Evidence from nonstarved and long-term serum-deprived glioma C6 cells.

Authors:  Dorota Suplat; Patryk Krzemiński; Pawel Pomorski; Jolanta Barańska
Journal:  Purinergic Signal       Date:  2007-02-21       Impact factor: 3.765

Review 4.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

5.  Coupling of P2Y receptors to G proteins and other signaling pathways.

Authors:  Laurie Erb; Gary A Weisman
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012 Nov-Dec

6.  Insulin-like growth factor-1 regulates platelet activation through PI3-Kalpha isoform.

Authors:  Soochong Kim; Analia Garcia; Shaun P Jackson; Satya P Kunapuli
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

Review 7.  Ceramide and ceramide 1-phosphate in health and disease.

Authors:  Lide Arana; Patricia Gangoiti; Alberto Ouro; Miguel Trueba; Antonio Gómez-Muñoz
Journal:  Lipids Health Dis       Date:  2010-02-05       Impact factor: 3.876

8.  Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect.

Authors:  Peirang Cao; Jun-Ichi Hanai; Preeti Tanksale; Shintaro Imamura; Vikas P Sukhatme; Stewart H Lecker
Journal:  FASEB J       Date:  2009-04-30       Impact factor: 5.191

9.  AR collaborates with ERα in aromatase inhibitor-resistant breast cancer.

Authors:  Yassine Rechoum; Daniela Rovito; Domenico Iacopetta; Ines Barone; Sebastiano Andò; Nancy L Weigel; Bert W O'Malley; Powel H Brown; Suzanne A W Fuqua
Journal:  Breast Cancer Res Treat       Date:  2014-09-02       Impact factor: 4.872

10.  Role of protein kinase C in cholinergic stimulation of lacrimal gland protein secretion.

Authors:  D Zoukhri; R R Hodges; D M Dicker; D A Dartt
Journal:  FEBS Lett       Date:  1994-08-29       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.